// App-Quantinova.ai

EP682 : A SURVEY OF HEALTHCARE PROFESSIONALS IN THE UNITED KINGDOM TO DESCRIBE CURRENT PATHWAYS AND MANAGEMENT PRACTICES IN CHRONIC MYELOID LEUKAEMIA: THE ADAPT CML SURVEY

Researchers

Presenter

  • Mhairi Copland

Principal Investigators

  • Katherine Gibson

  • Dragana Milojkovic

  • Nicholas C.P Cross

  • Brian Huntly

  • Jennifer Billot

  • Jacqueline Ryan

  • Adam Mead

Medical Centers

  • Paul O'Gorman Leukaemia Research Centre, University of Glasgow, Gartnavel General Hospital,Glasgow,United Kingdom

  • Department of Medicine and Wellcome -MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, England, United Kingdom

  • OPEN VIE,Marlow,United Kingdom

  • MRC Weatherall Institute of Molecular Medicine, NIHR Oxford Biomedical Research Centre Haematology Theme, Radcliffe Department of Medicine, University of Oxford,Oxford,United Kingdom

  • St Marys Hospital, Imperial CollegeHealthcare NHS Trust, London, UK

  • Faculty of Medicine, University of Southampton, Southampton, United Kingdom

  • Novartis Pharmaceuticals UK Ltd,London,United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved